Dr. Pieter Cullis, a professor in UBC’s department of biochemistry and molecular biology, has been…
pthomsonJanuary 27, 2022
An international team led by a former UBC postdoctoral fellow in medical genetics has uncovered…
pthomsonJanuary 26, 2022
Today, BioTalent Canada announced the launch of a new program: the Skilled Newcomer Internships for…
pthomsonJanuary 26, 2022
For the past three decades, myeloid malignancies such as myelodysplastic syndrome (MDS) and acute myeloid…
pthomsonJanuary 25, 2022
Sarcomas are cancers of mesenchymal origin with the potential to arise in diverse anatomic locations.…
pthomsonJanuary 25, 2022
This week, we profile a publication in Cell Reports Methods from Vincent Hanlon (pictured) and…
pthomsonJanuary 24, 2022
The health of the communities we live in relies on well functioning ecosystems that provide…
pthomsonJanuary 24, 2022
Myelodysplastic syndrome (MDS) represents a group of diseases often referred to as bone marrow failure,…
sciencecityNovember 7, 2017
In an interview with the University of British Columbia student newspaper nearly 20 years ago,…
sciencecityNovember 6, 2017
For Dr. Rankin (pictured, right), a leader in the field of habituation research, understanding the way that…
sciencecityNovember 3, 2017
Sierra Oncology, Inc., a clinical stage drug development company focused on advancing next generation DNA…
sciencecityNovember 3, 2017
Informing a grieving family that their child has suddenly died of unexplainable causes is a…
sciencecityNovember 2, 2017
InMed Pharmaceuticals, Inc., a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based…
sciencecityNovember 1, 2017
Researchers at SFU and Brazil’s Federal University of Rio de Janeiro (UFRJ) are collaborating to determine why…
sciencecityOctober 31, 2017
The B.C. Lung Screen Trial at Vancouver General Hospital is currently recruiting 2,000 individuals from…
sciencecityOctober 31, 2017
